Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP340628.RAAwhU_cwNzvgWfE9rD8g5y5Zs8s8swAm63ubkuBBGGgo130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340628.RAAwhU_cwNzvgWfE9rD8g5y5Zs8s8swAm63ubkuBBGGgo130_provenance.
• assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287198.RAWM33UMAEUiJWB5kapoYeOrZAkELZgJ9jire7p-aPlyc130_provenance.
• NP287195.RAm9VYOxPNTdSvliB3BT1hqyeS-cAvWrNoJK2l5JLy2Ak130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287195.RAm9VYOxPNTdSvliB3BT1hqyeS-cAvWrNoJK2l5JLy2Ak130_provenance.
• NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287197.RAj49Tq6fQVFysLJaog5vioMbawcrEHnbzmYR9aq7s_hU130_provenance.
• NP287194.RAFsPeWfrjg98iXy8hRapu-bFYn1PgovtbosVcZ1_4fp4130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287194.RAFsPeWfrjg98iXy8hRapu-bFYn1PgovtbosVcZ1_4fp4130_provenance.
• NP287196.RAFM1tLWNtb1ZBt3jXHLzhDhxNBDbRDihvVqIANQzkeCg130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287196.RAFM1tLWNtb1ZBt3jXHLzhDhxNBDbRDihvVqIANQzkeCg130_provenance.
• NP287199.RAGUG_QmoEuGURrzlAHYqscjg_QoOajh_IJbV4GcC5XgY130_assertion description "[Here, we report that flufenamic acid shows two opposing effects on COX-2 expression; it induces COX-2 expression in the colon cancer cell line (HT-29) and macrophage cell line (RAW 264.7); conversely, it inhibits tumor necrosis factor alpha (TNFalpha)- or lipopolysaccharide (LPS)-induced COX-2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287199.RAGUG_QmoEuGURrzlAHYqscjg_QoOajh_IJbV4GcC5XgY130_provenance.